1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. CANNABIDIOL MARKET BY SOURCE
5.1. Introduction
5.2. Hemp
5.3. Marijuana
6. CANNABIDIOL MARKET BY PRODUCT TYPE
6.1. Introduction
6.2. Oil
6.3. Tablets & Capsules
6.4. Gummies
6.5. Others
7. CANNABIDIOL MARKET BY SALES TYPE
7.1. Introduction
7.2. B2B
7.3. B2C
8. CANNABIDIOL MARKET BY END-USER
8.1. Introduction
8.2. Pharmaceuticals
8.3. Personal Care & Cosmetics
8.4. Food & Beverage
8.5. Others
9. CANNABIDIOL MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. ENDOCA
11.2. Cannoid, LLC
11.3. Elixinol Wellness Limited
11.4. NuLeaf Naturals, LLC (High Tide Inc.)
11.5. Isodiol International, Inc.
11.6. Pharmahemp d.o.o.
11.7. Aurora Cannabis Inc.
11.8. Canopy Growth Corporation
11.9. CV Sciences, Inc
11.10. Medical Marijuana Inc
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES